| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.8 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.018 | 0.8 |